Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$7.42
-0.09-1.20%
Pre-Market: 5:43 PM EDT
15 minutes delayed
Comments
Loading...
Cormedix (NASDAQ:CRMD) Stock, Analyst Ratings, Price Targets, Forecasts
Cormedix Inc has a consensus price target of $13.17 based on the ratings of 6 analysts. The high is $19 issued by JMP Securities on April 9, 2024. The low is $9 issued by RBC Capital on August 15, 2024. The 3 most-recent analyst ratings were released by Rodman & Renshaw, RBC Capital, and Needham on August 26, 2024, August 15, 2024, and August 15, 2024, respectively. With an average price target of $10.67 between Rodman & Renshaw, RBC Capital, and Needham, there's an implied 43.76% upside for Cormedix Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Rodman & Renshaw
RBC Capital
Needham
Truist Securities
JMP Securities
1calculated from analyst ratings
Analyst Ratings for Cormedix
Data brought to you by Benzinga APIs
FAQ
What is the target price for Cormedix (CRMD) stock?
The latest price target for Cormedix (NASDAQ:CRMD) was reported by Rodman & Renshaw on August 26, 2024. The analyst firm set a price target for $13.00 expecting CRMD to rise to within 12 months (a possible 75.20% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cormedix (CRMD)?
The latest analyst rating for Cormedix (NASDAQ:CRMD) was provided by Rodman & Renshaw, and Cormedix initiated their buy rating.
When was the last upgrade for Cormedix (CRMD)?
There is no last upgrade for Cormedix
When was the last downgrade for Cormedix (CRMD)?
There is no last downgrade for Cormedix.
When is the next analyst rating going to be posted or updated for Cormedix (CRMD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cormedix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cormedix was filed on August 26, 2024 so you should expect the next rating to be made available sometime around August 26, 2025.
Is the Analyst Rating Cormedix (CRMD) correct?
While ratings are subjective and will change, the latest Cormedix (CRMD) rating was a initiated with a price target of $0.00 to $13.00. The current price Cormedix (CRMD) is trading at is $7.42, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.